How the cell and gene therapy market is taking shape
Cell and gene therapy (C>) represents a major advance in medical treatments by directly targeting the root causes of diseases…
Cell and gene therapy (C>) represents a major advance in medical treatments by directly targeting the root causes of diseases…
AI and supervised machine learning have considerable benefits for clinical trials. The first episode in this GlobalData-produced series by Zelta…
A synthetic active pharmaceutical ingredient (API) can offer a crucial option for drug manufacturing. Yet there can be many complexities…
The last decade has seen a significant increase in data-focused and online technologies used in clinical trials, adding to the…
The clinical supply chain in Africa is striving to manage the impact of the US decision to withdraw from the…
Dementia affects millions of people worldwide, causing a serious impact on the economy and the healthcare system. Alzheimer’s disease (AD)…
As clinical research continues evolving to become more innovative and efficient, adaptive trials, specifically platform trials, are leading the charge.…
Cell and gene therapies (C>s) work by either introducing healthy cells into a patient's body (cell therapy) or by modifying…
With the rise of electronic data capture (EDC) has come a raft of regulations on data use such as the…
The previous 12 months have seen considerable progress in cell and gene therapies, with the first solid tumor products receiving…